drugset / Trial / NCT00482937
Safety and Pharmacodynamic Study of CD-NP
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to establish the safety of CD-NP in normal human volunteers.
Timeline
- Start
- 2007-01
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cenderitide | Peptide | — | — |